The Smart Inhaler Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Smart Inhaler Market is estimated to be USD 19.91 million in 2017 and predicted to rise to USD 268.6 million by 2022 with a CAGR of 68.27%. The market is segmented by Product type (Nebulizers, Inhalers [Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs)]), Disorder (Chronic Obstructive Pulmonary Disease, Asthma, Other), End-user (Patients, R&D, Others). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
Rise in air pollution which causes disorders like asthma and COPD, inclination of patients towards digitalized medical devices, increasing aging population, rising awareness about medication, rising investments in R&D of medical devices, growing respiratory diseases, new product innovations in medical industry and the technology advancements in the pharma-medical devices industry are driving the Global Smart Inhalers Market. However, limitations in data privacy, high costs and lack of availability in many regions are hindering the market growth.
In Inhaler segment, metered dose inhalers accounted for the highest share while dry powder inhalers projected to have the fastest growing rate. In end-users, patients segment accounted for the largest share due to rise in prevalence of asthma and COPD.
North America has the largest share in terms of revenue and product due to the high awareness about the digital medications, presence of large private companies and the favorable reimbursements in the medical sector. However, Asia-Pacific region is anticipated to have the fastest growing rate due to the high investments by the government organizations and private companies in the medical industry, growth in aging population and emerging economies like China and India.
Major companies like Global Smart Inhaler Market are Vectura Group plc, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca plc, Adherium Limited, Cohero Health, LLC, Propeller Health, GlaxoSmithKline plc and OPKO Health, Inc.
Browse through the full report at “https://www.marketdataforecast.com/market-reports/smart-inhaler-market-6038/” and checkout our recent reports in the Health it category at “https://www.marketdataforecast.com/subcategory/healthcare-it-17/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.